Catechol-O-methyltransferase gene val158met polymorphism and depressive symptoms during early childhood

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 162, Issue 3, 2013, Pages 245-252

  Sheikh, Haroon I ^a   Kryski, Katie R ^a   Smith, Heather J ^a   Dougherty, Lea R ^b   Klein, Daniel N ^c   Bufferd, Sara J ^c   Singh, Shiva M ^a   Hayden, Elizabeth P ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF MARYLAND   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Anxiety; Catechol O methyltransferase; Depression; Internalizing; Replication; Val158met

Indexed keywords

CATECHOL METHYLTRANSFERASE; CATECHOLAMINE;

ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CATECHOLAMINE METABOLISM; CHILD; COGNITION; DEPRESSION; DNA POLYMORPHISM; EMPLOYMENT; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MATERNAL AGE; OPPOSITIONAL DEFIANT DISORDER; PATERNAL AGE; PRESCHOOL CHILD; PRIORITY JOURNAL;

ALLELES; ANXIETY; CATECHOL O-METHYLTRANSFERASE; CHILD, PRESCHOOL; DEPRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; METHIONINE; POLYMORPHISM, GENETIC; VALINE;

EID: 84875319969     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32141     Document Type: Article

References (77)

1. Aberg E, Fandiño-Losada A, Sjöholm LK, Forsell Y, Lavebratt C. 2011. The functional Val(158)Met polymorphism in catechol-O-methyltransferase (COMT) is associated with depression and motivation in men from a Swedish population-based study. J Affect Disord 129:158-166.
2. American Psychiatric Association. 2000 Diagnostic and statistical manual of mental disorders, 4th edition. Washington, DC: American Psychiatric Association.
3. Arnsten AF, Li BM. 2005. Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57:1377-1384.
4. Baekken PM, Skorpen F, Stordal E, Zwart JA, Hagen K. 2008. Depression and anxiety in relation to catechol-O-methyltransferase val158met genotype in the general population: The Nord-Trøndelag Health Study (HUNT). BMC Psychiatry 25:48.
5. Bardone AM, Moffitt TE, Caspi A, Dickson N, Silva PA. 1996. Adult mental health and social outcomes of adolescent girls with depression and conduct disorder. Dev Psychopathol 8:811-829.
6. Barnett JH, Heron J, Ring SM, Golding J, Goldman D, Xu K, Jones PB. 2007. Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry 164:142-9.
7. Bierut LJ, Heath AC, Bucholz KK, Dinwiddie SH, Madden PA, Statham DJ, et al. 1999. Major depressive disorder in a community-based twin sample: Are there different genetic and environmental contributions for men and women? Arch Gen Psychiatry 56:557-563.
8. Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, Posthuma D, et al. 2011. Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry 16:516-532.
9. Brahe C, Bannetta P, Meera-Khan P, Arwert F, Serra A. 1986. Assignment of the catechol-O-methyltransferase gene to human chromosome 22 in somatic cell hybrids. Hum Genet 74:230-234.
10. Brocki K, Clerkin SM, Guise KG, Fan J, Fossella JA. 2009. Assessing the molecular genetics of the development of executive attention in children: Focus on genetic pathways related to the anterior cingulate cortex and dopamine. Neuroscience 164:241-246.
11. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al. 2004. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807-821.
12. Chen C, Chen C, Moyzis R, Dong Q, He Q, Zhu B, et al. 2011. Sex modulates the associations between the COMT gene and personality traits. Neuropsychopharmacology 36:1593-1598.
13. Demetrovics Z, Varga G, Szekely A, Vereczkei A, Csorba J, Balazs H, et al. (2010) Association between novelty seeking of opiate-dependent patients and the catechol-O-methyltransferase Val(158)Met polymorphism. Compr Psychiatry 51:510-515.
14. Domschke K, Deckert J, O'donovan MC, Glatt SJ. 2007. Meta-analysis of COMT val158met in panic disorder: Ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet 144B:667-673.
15. Dremencov E, El Mansari M, Blier P. 2009. Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area. J Psychiatry Neurosci 4:223-229.
16. Drevets WC, Price JL, Furey ML. 2008. Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Struct Funct 213:93-118.
17. Drury SS, Theall KP, Smyke AT, Keats BJB, Egger HL, Nelson CA, et al. 2010. Modification of depression by COMT val158met polymorphism in children exposed to early severe psychosocial deprivation. Child Abuse Neglect 34:387-395.
18. Dunn LM, Dunn LM. 1997. Peabody picture vocabulary test, 3rd edition. Circle Pines, Minnesota: American Guidance Service.
19. Egger HL, Erkanli A, Keeler G, Potts E, Walter BK, Angold A. 2006. Test-retest reliability of the preschool age psychiatric assessment (PAPA). J Am Acad Child Adolesc Psychiatry 45:538-549.
20. Eley TC, Stevenson J. 1999. Exploring the covariation between anxiety and depression symptoms: A genetic analysis of the effects of age and sex. J Child Psychol Psych 40:1273-1282.
21. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D. 2003. Genetic origins of anxiety in women: A role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet 13 1 33-41.
22. Evans J, Xu K, Heron J, Enoch MA, Araya R, Lewis G, et al. 2009. Emotional symptoms in children: The effect of maternal depression, life events, and COMT genotype. Am J Med Genet B Neuropsychiatr Genet. 150B:209-218.
23. Fergusson DM, Woodward LJ. 2002. Mental health, educational and social role outcomes of adolescents with depression. Arch Gen Psych 59:225-231.
24. Fox NA, Henderson HA, Marshall PJ, Nichols KE, Ghera MM. 2005. Behavioral inhibition: Linking biology and behavior within a developmental framework. Annu Rev Psychol 56:235-262.
25. Gadow KD, Sprafkin, J. 1997. Early childhood inventory-4 norms manual. New York: Checkmate Plus.
26. Girault JA, Greengard P. 2004. The neurobiology of dopamine signaling. Arch Neurol 61:641-644.
27. Goldman-Rakic PS. 1998. The cortical dopamine system: Role in memory and cognition. Adv Pharmacol 42:707-711.
28. Golimbet VE, Alfimova MV, Gritsenko IK, Ebstein RP. 2007. Relationship between dopamine system genes and extraversion and novelty seeking. Neurosci Behav Physiol 37:601-606.
29. Gotlib IH, Joormann J. 2010. Cognition and depression: Current status and future directions. Annu Rev Clin Psychol 6:285-312.
30. Hamilton SP, Slager SL, Heiman GA, Deng Z, Haghighi F, Klein DF, et al. 2002. Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol Psychiatry 51:591-601.
31. Hettema JM, An SS, Bukszar J, van den Oord EJ, Neale MC, Kendler KS, Chen X. 2008. Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes. Biol Psychiatry 64:302-310.
32. Hofstra MB, van der Ende J, Verhulst FC. 2000. Continuity and change of psychopathology from childhood into adulthood: A 14-year follow-up study. J Am Acad Child Adolesc Psychiatry 39:850-858.
33. Hollingshead AB. 1975. Four factor index of social status. Unpublished manuscript.
34. Hosák L. 2007. Role of the COMT gene val158met polymorphism in mental disorders: A review. Eur Psychiatry 22:276-281.
35. Hutchison KE, Stallings M, McGeary J, Bryan A. 2004. Population stratification in the candidate gene study: Fatal threat or red herring? Psychol Bull 130:66-79.
36. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. 2001. Replication validity of genetic association studies. Nat Genet 29:306-309.
37. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, et al. 1999. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45:1178-1189.
38. Kendler KS, Prescott CA. 1999. A population-based twin study of lifetime major depression in men and women. Arch Gen Psychiatry 56:39-44.
39. Kendler KS, Gatz M, Gardner CO, Pedersen NL. 2006. A Swedish national twin study of lifetime major depression. Am J Psychiatry 163:109-114.
40. Kessler RC, McGonagale KA, Zhao S, et al. 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arc Gen Psychiatry 51:8-19.
41. Krishnan V, Nestler EJ. 2010. Linking molecules to mood: New insight into the biology of depression. Am J Psychiatry 167:1305-1320.
42. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. 1996. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
43. Lavigne JV, Arend R, Rosenbaum D, Binns HJ, Christoffel KK, Gibbons RD. 1998. Psychiatric disorders with onset in the preschool years: II: Correlates and predictors of stable case status. J Am Acad Child Adolesc Psychiatry 37:1255-1261.
44. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melén K, Julkunen I, et al. 1995. Kinetics of human soluble and membranebound catechol-O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202-4210.
45. Marazziti D, Consoli G, Picchetti M, Carlini M, Faravelli L. 2010. Cognitive impairment in major depression. Eur J Pharmacol 626:83-86.
46. Martinot M, Bragulat V, Artiges E, Dollé F, Hinnen F, Jouvent R, Martinot J. 2001. Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. Am J Psychiatry 158:314-316.
47. Massat I, Souery D, Del-Favero J, Nothen M, Blackwood D, Muir W, et al. 2005. Association between COMT (val158met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol Psychiatry 10:598-605.
48. Massat I, Kocabas NA, Crisafulli C, Chiesa A, Calati R, Linotte S, et al. 2011. COMT and age at onset in mood disorders: A replication and extension study. Neurosci Lett 438:218-221.
49. McGrath M, Kawachi I, Ascherio A, Colditz GA, Hunter DJ, De Vivo I. 2004. Association between catechol-O-methyltransferase and phobic anxiety. Am J Psychiatry 161:1703-1705.
50. Mesman J, Koot H. 2001. Early preschool predictors of preadolescent internalizing and externalizing DSM-IV diagnosis. J Am Acad Child Adolesc Psychiatry 40:1029-1036.
51. Mesman J, Bongers IL, Koot HM. 2001. Preschool developmental pathways to preadolescent internalizing and externalizing problems. J Chil Psychol Psych 42:679-689.
52. Meyer JH. 2012. Neuroimaging markers of cellular function in major depressive disorder: Implications for therapeutics, personalized medicine, and prevention. Clin Pharmacol Ther 91:201-214.
53. Meyer-Lindenberg A, Weinberger DR. 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7:818-827.
54. Meyers N, Fromm S, Luckenbaugh DA, Drevets WC, Hasler G. 2011. Neural correlates of sleepiness induced by catecholamine depletion. Psychiatry Res 194:73-78.
55. Middeldorp CM, Slof-Op't Landt MC, Medland SE, van Beijsterveldt CE, Bartels M, et al. 2010. Anxiety and depression in children and adults: Influence of serotonergic and neurotrophic genes? Genes Brain Behav 9:808-816.
56. Mier D, Kirsch P, Meyer-Lindenberg A. 2010. Neural substrates of pleiotropic action of genetic variation in COMT: A meta-analysis. Mol Psychiatry 15:918-927.
57. Mill J, Dempster E, Caspi A, Williams B, Moffitt T, Craig I. 2006. Evidence for monozygotic twin (MZ) discordance in methylation level at two CpG sites in the promoter region of the catechol-O-methyltransferase (COMT) gene. Am J Med Genet B Neuropsychiatr Genet 141B:421-425.
58. Nestler EJ, Carlezon WA Jr. 2006. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151-1159.
59. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. 2002. Neurobiology of depression. Neuron 34:13-25.
60. Nobile M, Rusconi M, Bellina M, Marino C, Giorda R, Carlet O, et al. 2010. COMT val158met polymorphism and socioeconomic status interact to predict attention deficit/hyperactivity problems in children aged 10-14. Eur Child Adolesc Psychiatry 19:549-557.
61. Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. 2002. National trends in the outpatient treatment of depression. JAMA 287:203-209.
62. Opmeer EM, Kortekaas R, Aleman A. 2010. Depression and the role of genes involved in dopamine metabolism and signalling. Prog Neurobiol 92:112-133.
63. Pogorelov VM, Rodriguiz RM, Insco ML, Caron MG, Wetsel WC. 2005. Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology 30:1818-1831.
64. Reif A, Lesch KP. 2003. Toward a molecular architecture of personality. Behav Brain Res 139:1-20.
65. Reiger DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. 1993. The de facto US mental and addictive disorders service system: Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Arc Gen Psychiatry 50:85-94.
66. Rothe C, Koszycki D, Bradwejn J, King N, Deluca V, Tharmalingam S, et al. 2006. Association of the val158met catechol-O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology 31:2237-2242.
67. Ruhe HG, Mason NS, Schene AH. 2007. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies. Mol Psychiatry 12:331-359.
68. Ruiz-Sanz JI, Aurrekoetxea I, del Agua AR, Ruiz-Larrea MB. 2007. Detection of catechol-O-methyltransferase val158met polymorphism by a simple one-step tetra-primer amplification refractory mutation system-PCR. Mol Cell Prob 21:202-207.
69. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. 2003. Mapping cortical change across the human life span. Nat Neurosci 6:309-315.
70. Sprafkin J, Volpe RJ, Gadow KD, Nolan EE, Kelly K. 2002. A DSM-IV referenced screening instrument for preschool children: The Early Childhood Inventory-4. J Am Acad Chil Adol Psych 41:604-612.
71. Wahlstrom D, White T, Hooper CJ, Vrshek-Schallhorn S, Oetting WS, Brott MJ, et al. 2007. Variations in the catechol-O-methyltransferase polymorphism and prefrontally guided behaviors in adolescents. Biol Psychiatry 61:626-632.
72. Willner P. 1995. Animal models of depression: Validity and applications. Adv Biochem Psychopharmacol 49:19-41.
73. Woodward LJ, Fergusson DM. 2001. Life course outcomes of young people with anxiety disorders in adolescence. J Am Acad Child Adolesc Psychiatry 40:1086-1093.
74. Worda C, Sator MO, Schneeberger C, Jantschev T, Ferlitsch K, Huber JC. 2003. Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Hum Reprod 18:262-266.
75. Wray NR, James MR, Dumenil T, Handoko HY, Lind PA, Montgomery GW, et al. 2008. Association study of candidate variants of COMT with neuroticism, anxiety and depression. Am J Med Genet B Neuropsychiatr Genet 147:1314-1318.
76. Zahn-Waxler C, Klimes-Dougan B, Slattery MJ. 2000. Internalizing problems of childhood and adolescence: Prospects, pitfalls, and progress in understanding the development of anxiety and depression. Dev Psychopathol 12:443-466.
77. Zintzaras E, Lau J. 2008. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61:634-645.